Relationship provides Mayo Clinic early access to next-generation sequencing technologies; Illumina will obtain insights for ongoing product development

SAN DIEGO & ROCHESTER, Minn.-- Illumina, Inc. (NASDAQ: ILMN) today announced it has entered an agreement with Mayo Clinic to make advancements in next-generation sequencing technology with the intent to accelerate Mayo's delivery of genetic and genomic expertise. Together, the organizations plan to integrate existing services and software tools and employ new, innovative solutions to improve Mayo Clinic's reporting workflows for [...]

Waters Expands CORTECS Analytical Column Portfolio

New Liquid Chromatography Columns Allow Scientists to Fine Tune Their Chromatographic Separations and Maintain Maximum Performance MILFORD, Mass.-- Waters Corporation (NYSE:WAT) today expanded its CORTECS® Columns product line with the introduction of two new chemistries: Waters® CORTECS T3 and CORTECS Shield RP18. These new CORTECS column chemistries allow scientists to obtain more information per analysis and reduce the cost of analyzing complex [...]

Fluidigm Introduces High-Parameter Maxpar Mass Cytometry Panels for Immuno-Oncology Research

A comprehensive and flexible approach to deeply profile T cell phenotypes and function in immune checkpoint response SOUTH SAN FRANCISCO, Calif. -- Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of a modular set of high-parameter Maxpar® mass cytometry panels for immuno-oncology research. Designed for use with Helios™ and CyTOF® systems, the Immuno-Oncology Maxpar Panels enable researchers [...]

Nanomedical Diagnostics CEO and CTO to Introduce Electronic Label-Free Assay Based on Field Effect Biosensing Technology at IDTechEx Show

Ross Bundy and Dr. Brett Goldsmith will share how AGILE R100 provides small therapeutics companies access to the same data available to large pharma. San Diego, CA Speaking at the Sensors and Graphene & 2D Materials events on November 16 and 17, the two co-founders of Nanomedical Diagnostics will present the proprietary Field Effect Biosensing [...]

Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory in Boston

New services to enable U.S. biopharmaceutical companies to accelerate development of biosimilars Goettingen, Germany | Boston, MA, USA: Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, opened a new bioanalytical and biosafety testing laboratory yesterday in the major biotech hub of Boston, Massachusetts. This dedicated bioanalytical laboratory is designed to accommodate the rising demand for the [...]

BioGX Sample-Ready TM Technology Selected By NASA For Genetic Analysis Aboard The International Space Station

BIRMINGHAM, Ala.-- BioGX announced its Sample-Ready TM lyophilized qPCR technology was selected by the NASA WetLab-2 program to conduct genetic analysis aboard the International Space Station (ISS). BioGX core technology enables real-time PCR based scientific studies in the microgravity environment of the ISS. Julie Schonfeld, Project Manager of the NASA WetLab 2 program said, “The [...]

US Environmental Protection Agency Uses Certara’s Simcyp Simulator to Support Toxicological Triage

Simcyp Simulator allows population variability to be factored into risk-based prioritization PRINCETON, NJ – Certara®, the leading provider of decision support technology and consulting services for optimizing drug development and improving health outcomes, today announced that the U.S. Environmental Protection Agency (EPA) is using its Simcyp® Population-based Simulator to support the Agency’s high-throughput toxicity testing program. The [...]

NEW PARTNERSHIP BETWEEN SOPHIA GENETICS AND ARCHERDX CONTINUES TO DEMOCRATIZE DATA-DRIVEN MEDICINE

Hospitals and laboratories using the Sophia DDM® analytical platform in 35 countries will benefit from SOPHiA™ artificial intelligence combined with Archer® FusionPlex®, VariantPlex™, and Reveal ctDNA™ sample preparation kits LAUSANNE, Switzerland – Today, at the AMP 2016 Annual Meeting, Sophia Genetics, global leader in Data-Driven Medicine, and world-class Next-Generation Sequencing (NGS) assay developer ArcherDX, announced the [...]

Innovative Approach for Tracing Filaments in Dense 3D Neural Networks with Imaris 8.4

Dedicated to Neuroscientists - Imaris 8.4 Belfast - Bitplane, an Oxford Instruments Company and world leader in 2-4D image visualization, analysis and interpretation, have announced the launch of Imaris 8.4 in advance of the Society for Neuroscience Annual Meeting in San Diego. In recent years, a steady growth in sample clearing and labelling techniques such as [...]

Sirona Dx Expands Next Generation Sequencing Services to Include Oncomine Focus Assay for Pharmaceutical Clients

VANCOUVER, Wash. & CARLSBAD, Calif.--Sirona Dx, a leader in high complexity genomics and proteomics services, today announced it has adopted Thermo Fisher Scientific’s Oncomine Focus Assay to run on the Ion PGM System and will expand its drug development and next generation sequencing (NGS) services offered to pharmaceutical and clinical research clients. Sirona Dx recognizes [...]

Access IBO on Knowledge Center